Wake County, North Carolina; General Obligation Sep 08

  • ID: 2043517
  • September 2008
  • Region: North Carolina
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'AAA' rating, and stable outlook, to Wake County, N.C.'s series 2008A and 2008B general obligation (GO) public improvement and refunding bonds and affirmed its 'AAA' rating, with a stable outlook, on the county's existing GO debt. In our opinion, the rating reflects the county's: Strong regional economic base, which includes the state capital of Raleigh, N.C. and its access to the renowned Research Triangle Park; Diverse and growing property tax base, coupled with a property tax rate that is lower than comparable municipalities; Above-average wealth indicators; Strong financial performance and management with consistently healthy general fund reserves; and Manageable debt burden despite a significant capital improvement plan (CIP). The county's full faith and...

Companies mentioned in this report are:
- Wake Cnty

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Wake Cnty

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.